Arthrex forces Director review into PTAB's constitutional design

The Supreme Court held that APJ authority required a path for review by the presidentially appointed PTO Director.

United States v. Arthrex became the constitutional pivot point for PTAB final written decisions.

The Supreme Court held that administrative patent judges could not have unreviewable executive-branch authority over patent validity and supplied a remedy through Director review.

For PTAB practice, the case changed post-decision strategy. Parties gained a new institutional path to seek review of Board decisions by the PTO Director.

Every later discretionary-denial and Director-review story in IPDispatch should link back to Arthrex.

Arthrex forces Director review into PTAB's constitutional design

Source trail